Varex Imaging CorpVREX

Varex Imaging Corp Goodwill & Intangibles Disclosure

10-KFiled Nov 18, 20253 min read
GOODWILL AND INTANGIBLE ASSETS
    The following table reflects goodwill by reportable operating segment:
(In millions)MedicalIndustrialTotal
Balance at September 27, 2024$173.0 $118.0 $291.0 
Impairment of goodwill(93.9)— (93.9)
Foreign currency translation adjustments0.7 0.6 1.3 
Balance at October 3, 2025$79.8 $118.6 $198.4 
MedicalIndustrialTotal
Balance at October 3, 2025
Goodwill$173.7 $118.6 $292.3 
Accumulated impairment losses(93.9)— (93.9)
Total goodwill$79.8 $118.6 $198.4 
    The Company performs its annual goodwill impairment test as of the beginning of the fourth quarter of each fiscal year or whenever an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying amount. Refer to Note 1, Summary of Significant Accounting Policies, for further details concerning our annual goodwill impairment evaluation. During the three months ended July 4, 2025, the Company identified triggering events in its Industrial and Medical reporting units due to a sustained decline in its market capitalization, a sustained decline in its stock price, and downward revisions in its longer-term forecast received during the quarter, which included the impact of tariffs and MOFCOM Investigations announcements.
    As a result, in connection with the preparation of its financial statements for the three months ended July 4, 2025, the Company performed a quantitative impairment analysis for goodwill related to its Medical and Industrial reporting units. The fair value of the reporting units were determined using both an income approach utilizing the discounted cash flow method and market approach utilizing the public company market multiple method. Based on this analysis, the Company determined that the carrying amount of the Medical reporting unit exceeded fair value, and recorded a goodwill impairment charge of $93.9 million to its Medical reporting unit within impairment of goodwill in the Consolidated Statements of Operations. Additionally, based on the output of the analysis, the Company determined that the fair value of the Industrial reporting unit exceeded its carrying amount. Accordingly, no impairment charge was recorded relating to its Industrial reporting unit.
    The goodwill within the Medical reporting unit remains susceptible to future impairment charges. Any significant adverse change in the Company's near- or long-term projections or macroeconomic conditions would result in future impairment charges for the Medical reporting unit.    
    The following table reflects the gross carrying amount and accumulated amortization of the Company’s finite-lived intangible assets included in intangible assets, net in the Consolidated Balance Sheets:
October 3, 2025September 27, 2024
(In millions)Gross Carrying AmountAccumulated AmortizationNet Carrying AmountGross Carrying AmountAccumulated AmortizationNet Carrying Amount
Acquired existing technology
$74.9 $(65.5)$9.4 $73.8 $(63.5)$10.3 
Patents, licenses and other
6.2 (6.2)— 12.6 (12.6)— 
Customer contracts and supplier relationship
52.3 (47.7)4.6 52.8 (47.0)5.8 
Total intangible assets
$133.4 $(119.4)$14.0 $139.2 $(123.1)$16.1 
Amortization expense for intangible assets was $4.0 million, $9.9 million, and $13.7 million in fiscal years 2025, 2024, and 2023, respectively.
    As of October 3, 2025, the estimated future amortization expense of intangible assets with finite lives is as follows:
(In millions)
Fiscal Years:
2026$4.1 
20273.8 
20283.7 
20291.9 
20300.2 
Thereafter0.3 
Total$14.0 

Historical Timeline

Fiscal YearFiled
2025Nov 18, 2025Showing above
2024Nov 19, 2024
2023Nov 16, 2023
2022Nov 18, 2022
2021Nov 19, 2021
2020Nov 30, 2020

About Goodwill & Intangibles Disclosures

Goodwill and intangible asset disclosures reveal the premium paid in acquisitions and how management assesses whether that premium retains its value. Since goodwill is no longer amortized under US GAAP, the annual impairment test is the only mechanism that adjusts carrying values downward — making the assumptions behind that test critically important for investors.

Key signals: a history of goodwill impairments suggests management consistently overpays for acquisitions. Watch the gap between reporting unit fair value and carrying amount — when fair value exceeds carrying amount by less than 10-20%, a small decline in business performance could trigger a write-down. For finite-lived intangibles, examine useful life assumptions across customer relationships, technology, and trade names; aggressive estimates inflate near-term earnings. Compare total intangibles-to-total-assets ratios against peers to assess acquisition dependency. Rising goodwill as a percentage of equity can signal balance sheet fragility.

Other Available Disclosures

Income TaxesRevenueEarnings Per ShareFair ValuePP&ELeasesSegmentsDebtCommitmentsStock CompensationNew StandardsPay vs Performance